Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biochimica et Biophysica Acta - Proteins and Proteomics

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbapap.2017.11.013PMID 29203374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis

  2016cited by this paper
• Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.

  2015cited by this paper
• Molecular dynamics simulations of lipid membranes with lateral force: rupture and dynamic properties.

  2014cited by this paper
• In Silico Identification and Evaluation of Leads for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease Using Complex Based Pharmacophore Mapping and Virtual Screening

  2014cited by this paper
• Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates

  2013cited by this paper
• Variability in docking success rates due to dataset preparation

  2012cited by this paper
• In Silico Prediction and Analysis of Caenorhabditis EF-hand Containing Proteins

  2012cited by this paper
• REFMAC5 for the refinement of macromolecular crystal structures

  2011cited by this paper
• ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation.

  2010cited by this paper
• Dali server: conservation mapping in 3D

  2010cited by this paper
• Molecular replacement with MOLREP.

  2010cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.

  2008cited by this paper
• Peptidoglycan structure and architecture.

  2008cited by this paper
• RAPIDO: a web server for the alignment of protein structures in the presence of conformational changes

  2008cited by this paper
• Cytoplasmic steps of peptidoglycan biosynthesis.

  2008cited by this paper
• CHAINSAW: a program for mutating pdb files used as templates in molecular replacement

  2008cited by this paper
• Inference of macromolecular assemblies from crystalline state.

  2007cited by this paper
• 2D Depiction of Protein-Ligand Complexes

  2007cited by this paper
• 3,5-Dioxopyrazolidines, Novel Inhibitors of UDP-N- Acetylenolpyruvylglucosamine Reductase (MurB) with Activity against Gram-Positive Bacteria

  2006cited by this paper
• Identification and Characterization of Amino Acid Residues Essential for the Active Site of UDP-N-acetylenolpyruvylglucosamine Reductase (MurB) from Staphylococcus aureus*

  2006cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

  2004cited by this paper
• Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein–nucleic acid complex crystals

  2003cited by this paper
• Isolation and mutation site determination of the temperature-sensitive murB mutants of Staphylococcus aureus.

  2003cited by this paper
• Discovery of the first antibacterial small molecule inhibitors of MurB.

  2003cited by this paper
• A structural variation for MurB: X-ray crystal structure of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB).

  2001cited by this paper
• 4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurB.

  2000cited by this paper
• Automated protein model building combined with iterative structure refinement

  1999cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls.

  1996cited by this paper
• Structural classification of proteins: new superfamilies.

  1996cited by this paper
• An enzyme–substrate complex involved in bacterial cell wall biosynthesis

  1995cited by this paper
• Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

  1993cited by this paper
• Molecular dynamics with coupling to an external bath

  1984cited by this paper
• Cytoplasmic steps of peptidoglycan synthesis in Escherichia coli

  1982cited by this paper
• Polymorphic transitions in single crystals: A new molecular dynamics method

  1981cited by this paper
• An Extended Hückel Theory. I. Hydrocarbons

  1963cited by this paper

• Exploring the Antimycobacterial Potential of Purine‐Piperazine Hybrids via in Vitro and in Silico Approaches

  2026cites this paper
• Synthesis of O‐Prenylated O‐Glycosylated and O‐Benzylated Phenazines Derivatives and Their Antimicrobial and Molecular Docking Studies

  2025cites this paper
• Discovery of Novel Antimicrobial-Active Compounds and Their Analogues by In Silico Small Chemical Screening Targeting Staphylococcus aureus MurB

  2025cites this paper
• Determining the Antimycobacterial Action of Rottlerin Against Mycobacterium Species and Toxicity, Antioxidant Properties, and Therapeutic Target Affinity of Rottlerin

  2025cites this paper
• Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery.

  2024cites this paper
• Role of UDP‐N‐acetylmuramic acid in the regulation of MurA activity revealed by molecular dynamics simulations

  2024cites this paper
• In silico screening of dicoumarols as potential Mur B enzyme inhibitors in Mycobacterium tuberculosis: molecular docking, ADME, QSAR and MD simulations

  2024influential citation
• Reactive oxygen species-dependent anti-extended spectrum β-lactamases activity of multi-layer Ti3C2T : A novel approach for treating successfully P. aeruginosa and K. pneumoniae

  2024cites this paper
• The genetic landscape of antibiotic sensitivity in Staphylococcus aureus

  2024cites this paper
• Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents

  2023cites this paper
• Screening and molecular dynamics simulation of compounds inhibiting MurB enzyme of drug-resistant Mycobacterium tuberculosis: An in-silico approach

  2023cites this paper
• Mining the Flavoproteome of Brucella ovis, the Brucellosis Causing Agent in Ovis aries

  2022cites this paper
• Structural analysis of EhPSP in complex with 3-phosphoglyceric acid from Entamoeba histolytica reveals a basis for its lack of phosphoglycerate mutase activity.

  2021cites this paper
• Nuclear Receptor SHP Dampens Transcription Function and Abrogates Mitotic Chromatin Association of PXR and ERα via Intermolecular Interactions.

  2021cites this paper
• Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening

  2021cites this paper
• The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wall.

  2021cites this paper
• Opportunities for overcoming tuberculosis: emerging targets and their inhibitors.

  2021cites this paper
• Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors

  2020cites this paper
• Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall

  2020cites this paper
• Biochemical and biophysical characterization of the smallest pyruvate kinase from Entamoeba histolytica.

  2020cites this paper
• Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Mycobacterium tuberculosis

  2020cites this paper
• Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis

  2020cites this paper
• Deciphering the interaction of benzoxaborole inhibitor AN2690 with connective polypeptide 1 (CP1) editing domain of Leishmania donovani leucyl-tRNA synthetase

  2020cites this paper
• Crystal structure of O-Acetylserine sulfhydralase (OASS) isoform 3 from Entamoeba histolytica: Pharmacophore-based virtual screening and validation of novel inhibitors.

  2020cites this paper
• Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme

  2020cites this paper
• MnmE, a Central tRNA-Modifying GTPase, Is Essential for the Growth, Pathogenicity, and Arginine Metabolism of Streptococcus suis Serotype 2

  2019cites this paper
• Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen

  2019cites this paper
• Virtual screening approach and biochemical evaluation on MurB

  2019cites this paper
• In silico elucidation of novel anticancer lead molecules targeting human prostate specific gene-1 protein

  2018cites this paper
• Impact of Genomics on Clarifying the Evolutionary Relationships amongst Mycobacteria: Identification of Molecular Signatures Specific for the Tuberculosis-Complex of Bacteria with Potential Applications for Novel Diagnostics and Therapeutics

  2018cites this paper
• Peptidoglycan in Mycobacteria: chemistry, biology and intervention

  2018cites this paper
• Reaching toward underexplored targets in antibacterial drug design

  2018cites this paper